LIVE

Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video

Trending Now

US stocks suffered amid tech weakness, mixed data and geopolitical fears - Newsquawk Asia-Pac Market Open

Stocks hit by tech, Crude soars on geopols, while Bonds sell off continues - Newsquawk US Market Wrap

EU bourses & US futures fall as tech slips, Gilts remain for sale; key earnings & data ahead - Newsquawk US Market Open

APAC stocks subdued post-US losses and BoJ rate hold; EU & US futures fall on Meta and Microsoft - Newsquawk Europe Market Open

US stocks declined as participants digested earnings and mixed data releases - Newsquawk Asia-Pac Market Open

Stocks hit in midst of earnings season as Tech underperforms - Newsquawk US Market Wrap

US futures mixed, GOOGL beats, DXY lower ahead of US ADP, PCE Prices/GDP Advance & GBP awaits Budget - Newsquawk US Market Open

Alphabet climbed post-earnings; more mega-caps, UK budget & US refunding ahead - Newsquawk Europe Market Open

US stocks finished mixed with the attention on earnings, data and geopolitics - Newsquawk Asia-Pac Market Open

Markets chop to earnings, data, geopolitics, stimulus and supply - Newsquawk US Market Wrap

Moderna's second-quarter revenue jumps fivefold on coronavirus vaccine development

Business August 05, 2020

This article is being updated.

Previous article: CVS shares jump as retailer raises 2020 forecast after strong quarterly results Prev Next article: Avoid auto stocks, traders say as Ford shares rise on CEO switch Next

via CNBC August 5th 2020

MixedTimes.com
Business
Moderna's second-quarter revenue jumps fivefold on coronavirus vaccine development

© 2015-2024 MixedTimes All Rights Reserved.

Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video